{"slideshow_credits": null, "snippet": "Sun Pharmaceutical should have a better chance of getting a grip on Ranbaxy, though it is hardly getting a steal, Peter Thal Larsen of Reuters Breakingviews writes.", "abstract": "Sun Pharmaceutical should have a better chance of getting a grip on Ranbaxy, though it is hardly getting a steal, Peter Thal Larsen of Reuters Breakingviews writes.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"lastname": "LARSEN", "rank": 1, "firstname": "Peter", "role": "reported", "organization": "", "middlename": "Thal"}], "original": "By PETER THAL LARSEN"}, "web_url": "http://dealbook.nytimes.com/2014/04/07/drug-sale-shows-risk-in-japans-m-a-adventures/", "lead_paragraph": null, "headline": {"main": "Drug Sale Shows Risk in Japan's M.&A. Adventures", "kicker": "DealBook"}, "_id": "5342cb5538f0d82e0d98e30c", "word_count": "363", "multimedia": [{"height": 126, "url": "images/2014/04/08/business/dbpix-drug-ranbaxy/dbpix-drug-ranbaxy-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/04/08/business/dbpix-drug-ranbaxy/dbpix-drug-ranbaxy-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 426, "url": "images/2014/04/08/business/dbpix-drug-ranbaxy/dbpix-drug-ranbaxy-articleLarge.jpg", "legacy": {"xlarge": "images/2014/04/08/business/dbpix-drug-ranbaxy/dbpix-drug-ranbaxy-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "426"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/04/08/business/dbpix-drug-ranbaxy/dbpix-drug-ranbaxy-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/04/08/business/dbpix-drug-ranbaxy/dbpix-drug-ranbaxy-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-04-07T11:55:41Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "glocations", "value": "Japan", "rank": "2"}, {"name": "glocations", "value": "India", "rank": "1"}, {"name": "organizations", "value": "Ranbaxy Laboratories", "rank": "1"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}